-
In early 2008, Massachusetts hospitals will adopt a uniform policy not to charge patients or insurers for certain rare but serious adverse events, the Massachusetts Hospital Association announced recently.
-
When Cassandra Pundt, RN, CEN, decided to "ratchet down" from her demanding job as emergency department nursing manager at St. Mary's Hospital in Tucson, AZ, she created a position for herself that made use of her nursing skills and filled a void in the ED operation.
-
As Northern Hospital of Surry County moved from one manual solution for tracking registration errors to another, Terry Hancock, manager of patient access and customer service, says ...
-
The traumatic events of Sept. 11, 2001, now seared into the national consciousness, were particularly up close and personal for Michael Friedberg, FACHE, CHAM, who was on his way to work at Jersey City Medical Center, across the river from the World Trade Center, when the hijacked planes hit the towers.
-
-
Making patient bills more user-friendly -- not to mention ensuring that they are actually accurate -- continues to be a focus in the health care industry.
-
The management of patients with significant carotid artery disease, who need coronary artery bypass surgery (CABG), especially if the carotid disease is asymptomatic, is controversial. In the absence of randomized trials, this report of carotid artery stenting followed by CABG in 356 patients with severe asymptomatic carotid disease is of interest.
-
Peripheral arterial disease (PAD) is an exceedingly common manifestation of atherosclerosis. Its presence heralds an increased risk for death from coronary artery disease (CAD) and stroke, yet it continues to go unrecognized in a large proportion of patients.
-
The triggers of ventricular arrhythmia (tova Study) was a multicenter, prospective, cohort study that examined lifestyle and psychological triggers that might result in implantable cardioverter-defibrillator (ICD) shocks for ventricular tachycardia (VT) or ventricular fibrillation (VF).
-
The atrial fibrillation clopidogrel trial with Irbesartan for Prevention of Vascular Events (ACTIVE W) is a noninferiority trial comparing anticoagulation with warfarin to therapy with aspirin plus clopidogrel for stroke prevention in patients with atrial fibrillation.
